Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
James Heyward, MPH
PhD Candidate
Johns Hopkins School of Public Health
Poster(s):
(051) Assessment of Risk-Benefit Balance of Immune Checkpoint Inhibitors in a Real-World Lung Cancer Population
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST